ALBI Grade Enables Risk Stratification for Bleeding Events and Refines Prognostic Prediction in Advanced HCC Following Atezolizumab and Bevacizumab

Authors: Stefanini B, Fulgenzi CAM, Scheiner B, Korolewicz J, Cheon J, Nishida N, Ang C, Marron TU, Wu YL, Saeed A, Wietharn B, Rimassa L, Pirozzi A, Cammarota A, Pressiani T, Pinter M, Balcar L, Huang YH, Mehan A, Phen S, Vivaldi C, Salani F, Masi G, Bettinger D, Vogel A, Schönlein M, von Felden J, Schulze K, Wege H, Samson A, Galle PR, Kudo M, Manfredi GF, Celsa C, Awosika N, Cortellini A, Singal AG, Sharma R, Chon HJ, Tovoli F, Piscaglia F, Pinato DJ, D'Alessio A

Source: Journal of Hepatocellular Carcinoma, Vol Volume 12, Pp 671-683 (2025)

Subject Terms: hepatocellular carcinoma, albi, bleeding risk, systemic treatment, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://www.dovepress.com/albi-grade-enables-risk-stratification-for-bleeding-events-and-refines-peer-reviewed-fulltext-article-JHC; https://doaj.org/toc/2253-5969

Access URL: https://doaj.org/article/b800462a195647f6a2d842aef20fab5e

Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients

Authors: Antoni, C., Teufel, A., Vogelmann, R., Ebert, M., Balavoine, J., Giostra, E., Berning, M., Hampe, J., Boettler, T., Neumann-Haefelin, C., Thimme, R., De Gottardi, A., Rauch, A., Semmo, N., Ellenrieder, V., Gress, M., Herrmann, A., Stallmach, A., Hoffmann, D., Protzer, U., Kodal, A., Löbermann, M., Götze, T., Keitel-Anselmino, V., Lange, C.M., Zachoval, R., Mayerle, J., Maieron, A., Michl, P., Merle, U., Moradpour, D., Chave, J.-P., Muche, M., Epple, H.-J., Müller-Schilling, M., Kocheise, F., Müller, T., Tacke, F., Roeb, E., Rissland, J., Krawczyk, M., Schulze, P., Semela, D., Spengler, U., Rockstroh, J., Strassburg, C.P., Siebler, J., Schulze zur Wiesch, J., Piecha, F., von Felden, J., Jordan, S., Lohse, A., Sprinzl, M., Galle, P., Stauber, R., Strey, B., Steckstor, W., Schmiegel, W., Brockmeyer, N.H., Canbay, A., Trautwein, C., Uschner, F., Trebicka, J., Weber, T., Wedemeyer, H., Cornberg, M., Manns, M., Wietzke-Braun, P., Günther, R., Willuweit, K., Hilgard, G., Schmidt, H., Zizer, E., Backhus, J., Seufferlein, T., Al-Taie, O., Angeli, W., Beckebaum, S., Erhardt, A., Garrido-Lüneburg, A., Gattringer, H., Genné, D., Gschwantler, M., Gundling, F., Hametner, S., Schöfl, R., Haag, S., Heinzow, H., Heyer, T., Hirschi, C., Jussios, A., Kanzler, S., Kordecki, N., Kraus, M., Kullig, U., Wollschläger, S., Magenta, L., Beretta-Piccoli, B. Terziroli, Menges, M., Mohr, L., Muehlenberg, K., Niederau, C., Paulweber, B., Petrides, A., Pinkernell, M., Piso, R., Rambach, W., Reinhardt, L., Reiser, M., Riecken, B., Rieke, A., Roth, J., Schelling, M., Schlee, P., Schneider, A., Scholz, D., Schott, E., Schuchmann, M., Schulten-Baumer, U., Seelhoff, A., Stich, A., Stickel, F., Ungemach, J., Walter, E., Weber, A., Wege, H., Winzer, T., Abels, W., Adler, M., Audebert, F., Baermann, C., Bästlein, E., Barth, R., Barthel, K., Becker, W., Behrends, J., Benninger, J., Berger, F., Berzow, D., Beyer, T., Bierbaum, M., Blaukat, O., Bodtländer, A., Böhm, G., Börner, N., Bohr, U., Bokemeyer, B., Bruch, H.R., Bucholz, D., Buggisch, P., Matschenz, K., Petersen, J., Burkhard, O., Busch, N., Chirca, C., Delker, R., Diedrich, J., Frank, M., Diehl, M., Tal, A.O., Schneider, M., Dienethal, A., Dietel, P., Dikopoulos, N., Dreck, M., Dreher, F., Drude, L., Ende, K., Ehrle, U., Baumgartl, K., Emke, F., Glosemeyer, R., Felten, G., Hüppe, D., Fischer, J., Fischer, U., Frederking, D., Frick, B., Friese, G., Gantke, B., Geyer, P., Schwind, H.R., Glas, M., Glaunsinger, T., Goebel, F., Göbel, U., Görlitz, B., Graf, R., Gruber, H., Hartmann, C., Klag, C., Härter, G., Herder, M., Heuchel, T., Heuer, S., Hinrichsen, H., Seegers, B., Höffl, K.-H., Hörster, H., Sonne, J.-U., Hofmann, W.P., Holst, F., Hunstiger, M., Hurst, A., Jägel-Guedes, E., John, C., Jung, M., Kallinowski, B., Kapzan, B., Kerzel, W., Khaykin, P., Klarhof, M., Klüppelberg, U., Wolfratshausen, Klugewitz, K., Knapp, B., Knevels, U., Kochsiek, T., Körfer, A., Köster, A., Kuhn, M., Langekamp, A., Künzig, B., Link, R., Littman, M., Löhr, H., Lutz, T., Gute, P., Knecht, G., Lutz, U., Mainz, D., Mahle, I., Maurer, P., Mauss, S., Mayer, C., Möller, H., Heyne, R., Moritzen, D., Mroß, M., Mundlos, M., Naumann, U., Nehls, O., K, Ningel, R., Oelmann, A., Olejnik, H., Gadow, K., Pascher, E., Philipp, A., Pichler, M., Polzien, F., Raddant, R., Riedel, M., Rietzler, S., Rössle, M., Rufle, W., Rump, A., Schewe, C., Hoffmann, C., Schleehauf, D., Schmidt, W., Schmidt-Heinevetter, G., Fabris, J. Schmidtler-von, Schneider, L., Schober, A., Niehaus-Hahn, S., Schwenzer, J., Seidel, T., Seitel, G., Sick, C., Simon, K., Stähler, D., Stenschke, F., Steffens, H., Stein, K., Steinmüller, M., Sternfeld, T., Svensson, K., Tacke, W., Teuber, G., Teubner, K., Thieringer, J., Tomesch, A., Trappe, U., Ullrich, J., Urban, G., Usadel, S., von Lucadou, A., Weinberger, F., Werheid-Dobers, M., Werner, P., Winter, T., Zehnter, E., Zipf, A., Dietz, Julia, Graf, Christiana, Berg, Christoph P., Port, Kerstin, Deterding, Katja, Buggisch, Peter, Peiffer, Kai-Henrik, Vermehren, Johannes, Dultz, Georg, Geier, Andreas, Reiter, Florian P., Bruns, Tony, Schattenberg, Jörn M., Durmashkina, Elena, Gustot, Thierry, Moreno, Christophe, Trauth, Janina, Discher, Thomas, Fischer, Janett, Berg, Thomas, Kremer, Andreas E., Müllhaupt, Beat, Zeuzem, Stefan, Sarrazin, Christoph

Source: In JHEP Reports July 2024 6(7)

Axisymmetric drop shape analysis as penetration Langmuir balance.

Authors: Cabrerizo-Vilchez, M. A., Wege, H. A., Holgado-Terriza, J. A.

Source: Review of Scientific Instruments; May 1999, Vol. 70 Issue 5, p2438-2444, 7p

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma compared to patients with advanced solid tumours

Authors: Celsa, C., Cabibbo, G., Fulgenzi, C. AM, Scheiner, B., d'Alessio, A., Manfredi, G. F, Nishida, N., Ang, C., Marron, T.U., Saeed, A., Wietharn, B., Pinter, M., Cheon, J., Huang, Yi-Hsiang, Lee, Pei-Chang, Phen, S., Gampa, A., Pillai, A., Vivaldi, C., Salani, F., Masi, G., Roehlen, N., Thimme, R., Vogel, A., Schönlein, M., von Felden, J., Schulze, K., Wege, H., Galle, P.R., Kudo, M., Rimassa, L., Singal, A.G., Tomb, P. El, Ulahannan, S., Parisi, A., Chon, H. Jae, Hsu, Wei-Fan, Stefanini, B., Verzoni, E., Giusti, R., Veccia, A., Catino, A., Aprile, G., Guglielmini, P.F., Di Napoli, M., Ermacora, P., Antonuzzo, L., Rossi, E., Verderame, F., Zustovich, F., Ficorella, C., Di Pietro, F.R., Battelli, N., Negrini, G., Grossi, F., Bordonaro, R., Pipitone, S., Banzi, M., Ricciardi, S., Laera, L., Russo, A., De Giorgi, U., Cavanna, L., Sorarù, M., Montesarchio, V., Bordi, P., Brunetti, L., Pinto, C., Bersanelli, M., Cortellini, A., Cammà, C., Pinato, D.J.

Source: In Digestive and Liver Disease February 2024 56 Supplement 1:S76-S78

58P Efficacy and safety of liposomal irinotecan (nal-IRI) plus fluorouracil (5-FU) and leucovorin (LV) versus 5-FU/LV alone for advanced biliary tract cancer (BTC) after progression on gemcitabine-based therapy: A pooled analysis of the NIFTY and NALIRICC trials

Authors: Yoo, C., Saborowski, A., Hyung, J., Wenzel, P., Kim, I., Wege, H., Kim, K-P., Folprecht, G., Ryoo, B-Y., Schütt, P., Cheon, J., Goetze, T.O., Ryu, H., Lee, J.S., Vogel, A.

Source: In Annals of Oncology September 2024 35 Supplement 2:S235-S235

Identification of factors associated with primary refractoriness to atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma

Authors: Manfredi, G.F., Fulgenzi, C.A.M., D'Alessio, A., Celsa, C., Stefanini, B., Cheon, J., Ang, C., Marron, T.U., Saeed, A., Wietharn, B., Pressiani, T., Pinter, M., Scheiner, B., Huang, Yi-Hsiang, Phen, S., Naqash, A. Rafeh, Piscaglia, F., Lin, R. Po-Ting, -yen Lin, C., Dalbeni, A., Vivaldi, C., Masi, G., Thimme, R., Vogel, A., Schönlein, M., von Felden, J., Schulze, K., Wege, H., Galle, P.R., Kudo, M., Rimassa, L., Singal, A., Sharma, R., Cortellini, A., Jae Chon, H., Burlone, M., Pirisi, M., Pinato, D.J.

Source: In Digestive and Liver Disease February 2024 56 Supplement 1:S8-S9

53MO Nal-IRI and 5-FU/LV compared to 5-FU/LV in patients with cholangio- and gallbladder carcinoma previously treated with gemcitabine-based therapies (NALIRICC – AIO-HEP-0116)

Authors: Vogel, A., Wenzel, P., Folprecht, G., Schütt, P., Wege, H., Kretzschmar, A., Jacobasch, L., Ziegenhagen, N., Boeck, S., Kanzler, S., Mohm, J., Belle, S., Pink, D., Götze, T.O., Goekkurt, E., Graeven, U., Schaaf, M., Kirstein, M., Saborowski, A.

Source: In Annals of Oncology September 2022 33 Supplement 7:S563-S564

Standards und Entwicklungen in der Behandlung von Cholangiokarzinomen. (German)

Alternate Title: Standards and trends in the treatment of cholangiocarcinomas. (English)

Authors: Wege, H., Denecke, T., Petersen, C., Seehofer, D., Sinn, M.

Source: Best Practice Onkologie; Apr2020, Vol. 15 Issue 4, p134-140, 7p

FRI-138 - Serological diagnosis of early HCC in NASH: A German multicenter study

Authors: Best, J., Bechmann, L., Dechêne, A., Pflanz, K., Bedreli, S., Schotten, C., Berg, T., Fischer, J., Vogel, A., Bantel, H., Weinmann, A., Schattenberg, J., Huber, Y., Wege, H., Schulze, K., von Felden, J., Dominik, B., Thimme, R., Sinner, F., Schuette, K., Weiss, K.H., Berhane, S., Johnson, P., Gerken, G., Canbay, A.

Source: In Journal of Hepatology April 2018 68 Supplement 1:S421-S422

This result is not displayed to guests.
Login for full access.

FRI-100 - EpCAM-positive circulating tumor cells as liquid biomarker for early micrometastases and HCC recurrence risk

Authors: Schulze, K., von Felden, J., Krech, T., Ewald, F., Nashan, B., Lohse, A.W., Riethdorf, S., Wege, H.

Source: In Journal of Hepatology 2017 66(1) Supplement:S457-S457

This result is not displayed to guests.
Login for full access.

Indikationsstellung für operative Eingriffe und perioperatives Management bei Transplantierten und Immunsupprimierten. (German)

Authors: Wege, H., Benten, D., Sterneck, M.

Source: Allgemein und Viszeralchirurgie Up2date; Dec2016, Vol. 10 Issue 6, p453-464, 12p

This result is not displayed to guests.
Login for full access.

P1334 : A multicentre, randomised, open-label study comparing the efficacy and safety of two doses of Doxorubicin TransdrugTM to best standard of care in patients with advanced Hepatocellular Carcinoma (HCC) after sorafenib. The relive study

Authors: Merle, P., Pelletier, G., Habersetzer, F., Luca Frassineti, G., Pageaux, G.-P., Borbath, I., Gérolami, R., Sánchez Antolín, G., Bronowicki, J.-P., Horváth, Z., Touchefeu, Y., Maieron, A., Wege, H., Breder, V., Gabrail, N., Vasseur, B., Attali, P., Blanc, J.-F.

Source: In Journal of Hepatology April 2015 62 Supplement 2:S856-S857

P1310 : Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1) – a randomized, multidisciplinary, multinational phase III trial

Authors: Wege, H., Arnold, D., Bechstein, W.O., Bridgewater, J., Goldstein, D., Jensen, L.H., Kasper, S., Klümpen, H.J., Kunzmann, V., Lindig, U., Lohse, A.W., Nashan, B., Primrose, J., Rentsch, M., Shannon, J., Sinn, M., Weiss, K.H., Stein, A.

Source: In Journal of Hepatology April 2015 62 Supplement 2:S845-S845

P0302 : Constitutive gp130 activation accelerates transformation of proliferating human hepatocytes via increased levels of oxidative stress

Authors: Gil-Ibanez, I., Heim, D., Herden, J., Parplys, A.C., Borgmann, K., Schmidt-Arras, D., Lohse, A.W., Rose-John, S., Wege, H.

Source: In Journal of Hepatology April 2015 62 Supplement 2:S421-S422

Aktuelle Therapiekonzepte für lokale Cholangiokarzinome. (German)

Alternate Title: Current therapy concepts for local cholangiocarcinoma. (English)

Authors: Seehofer, D., Brunner, T.B., Wege, H.

Source: Der Onkologe; Nov2015, Vol. 21 Issue 11, p1054-1063, 10p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.